Osborne Matthew Scott 4
4 · Unum Therapeutics Inc. · Filed Feb 13, 2020
Insider Transaction Report
Form 4
Osborne Matthew Scott
Chief Financial Officer
Transactions
- Award
Stock Option
2020-02-11+160,400→ 160,400 totalExercise: $0.80Exp: 2030-02-11→ Common Stock (160,400 underlying)
Footnotes (1)
- [F1]25% of the shares vests on February 11, 2021, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Persons continuous service with the Issuer.